Kristin Hunt Karner, MD

Associate Professor (Clinical), University of Utah School of Medicine

Education

• Medical Degree—University of Nebraska
• Residency—Anatomic and Clinical Pathology, University of New Mexico
• Fellowship—Hematopathology, University of New Mexico
• Fellowship—Molecular Genetic Pathology, University of New Mexico

Current/Past Roles

• Senior Staff Pathologist, Henry Ford Health System, Detroit, MI (2010-2017)

Certification/Affiliations

• American Board of Pathology (Anatomic and Clinical Pathology, Hematopathology, Molecular Genetic Pathology)

Research Interests

• Lymphoid and myeloid malignancies
• Genetic aspects of myelodysplastic syndrome and other myeloid malignancies

Publications

• Ng DP, Karner KH. BCR-ABL1 (p210) transcript kinetics. Arch Pathol Lab Med. 2022;146(9):1140-1143.
• Ganapathi KA, Karner KH, Menon MP. Peripheral T-cell lymphomas of the T follicular helper type: clinical, pathological and genetic attributes. Hemato. 2022;3(1):268-286.
• Karner KH, Kohan JL, Tripp SR, et al. Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods. Int J Lab Hematol. 2020;42(2):e35-e37.
• Schumacher JA, Holgard VD, Sial F, et al. Detection and quantification of FLT3 internal tandem duplication mutations do not vary significantly between whole blood and blast-enriched samples. Am J Clin Pathol. 2020;153(2):251-257.
• Karner KH, George TI, Patel JL. Current aspects of clonal hematopoeisis: implications for clinical diagnosis. Ann Lab Med. 2019;39(6):509-514.